Back to JAZZ overview

JAZZ Jazz Pharmaceuticals PE ratio, current and historical analysis

As at Jun 20, 2024, the JAZZ stock has a price-to-earnings ratio of 20.53. This is based on the current EPS of $5.23 and the stock price of $107.36 per share.

JAZZ PE ratio history

How has JAZZ's PE ratio performed in the past

The mean historical PE ratio of Jazz Pharmaceuticals over the last ten years is 46.81. The current 20.53 P/E ratio is 56% lower than the historical average. In the past ten years, JAZZ's PE ratio peaked in the Sep 2014 quarter at 302.94, with a price of $160.56 and an EPS of $0.53. The Sep 2019 quarter marked the lowest point at 12.11, with a price of $128.14 and an EPS of $10.58.


Jazz Pharmaceuticals PE ratio by year

Maximum annual increase: 389.8% in 2014

Maximum annual decrease: -84.36% in 2015

Year PE ratio Change
2023 18.78 N/A
2022 N/A N/A
2021 N/A N/A
2020 38.56 138.17%
2019 16.19 -2.7%
2018 16.64 0.48%
2017 16.56 -0.36%
2016 16.62 -36.39%
2015 26.13 -84.36%
2014 167.07 389.8%

JAZZ average PE ratio chart

What is the average PE ratio of JAZZ for the past years

The current PE ratio of JAZZ is lower than the 5 and 10-year averages.

3-year avg
5-year avg
10-year avg
15-year avg

JAZZ PE vs peers

What is JAZZ's PE ratio compared to its peers

In comparison to its peer stock NVS, JAZZ's PE ratio is higher.

Stock name PE ratio Market cap
NVS Novartis AG 14.2 $214.69B
JAZZ Jazz Pharmaceuticals plc 20.64 $6.81B
TEVA Teva Pharmaceutical Industries Ltd N/A $19.21B
PRGO PERRIGO Co plc N/A $3.51B
SAGE Sage Therapeutics Inc N/A $668.02M

Frequently asked questions

What is Jazz Pharmaceuticals's PE ratio?

The price to earnings ratio for JAZZ stock as of Jun 20, 2024, stands at 20.53.

What is the 5-year average PE ratio for Jazz Pharmaceuticals (JAZZ)?

The 5-year average price to earnings ratio for JAZZ stock is 43.15.

What is the highest PE ratio for JAZZ?

In the last ten years, the Sep 2014 quarter recorded the highest quarterly PE ratio at 302.94.

How does the current PE ratio for JAZZ compare to its historical average?

JAZZ's current price to earnings ratio is 56% below its 10-year historical average.

How is JAZZ's PE ratio calculated (Jazz Pharmaceuticals PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 20, 2024), Jazz Pharmaceuticals's stock price is $107.36. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $5.23. Therefore, Jazz Pharmaceuticals's PE ratio for today is 20.53. PE RATIO(20.53) = STOCK PRICE($107.36) / TTM EPS($5.23)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.